US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lakewood-Amedex Biotherapeutics (Direct Listing)

2.45

+0.16006.99%

Post-market: 2.460.0100+0.41%19:58 EDT

Volume:386.27K

Turnover:939.68K

Market Cap:5.81M

PE:-0.24

High:2.57

Open:2.23

Low:2.20

Close:2.29

52wk High:98.20

52wk Low:1.66

Shares:2.37M

Float Shares:1.42M

Volume Ratio:3.94

T/O Rate:27.29%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-10.2000

EPS(LYR):-8.3987

ROE:-402.84%

ROA:-139.40%

PB:1.34

PE(LYR):-0.29

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Lakewood-Amedex Q2 FY26 Net Loss Widens to $3.77 Million; R&D Expense More than Doubled to $503,020

Lakewood-Amedex Biotherapeutics Announces Annual Shareholder Meeting

Lakewood-Amedex Biotherapeutics Announces Annual Shareholder Meeting

Lakewood-amedex Biotherapeutics Flags New Press Release Available on Nu-3 Resistance Data

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigerhkgo.com/stock/LABT"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABT\",,,,,undefined,":{"symbol":"LABT","market":"US","secType":"STK","nameCN":"Lakewood-Amedex Biotherapeutics (Direct Listing)","latestPrice":2.45,"timestamp":1787774400000,"preClose":2.29,"halted":0,"volume":386271,"hourTrading":{"tag":"盘后","latestPrice":2.46,"preClose":2.45,"latestTime":"19:58 EDT","volume":22855,"amount":55934.3683,"timestamp":1787788692071,"change":0.01,"changeRate":0.004082,"amplitude":0.037959},"delay":0,"changeRate":0.06986899563318784,"floatShares":1415552,"shares":2369700,"eps":-10.199959,"marketStatus":"Not Yet Opened","change":0.16,"latestTime":"08-26 16:00:00 EDT","open":2.23,"high":2.57,"low":2.2,"amount":939683.779326,"amplitude":0.161572,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.199959,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787817600000},"marketStatusCode":0,"adr":0,"listingDate":1776916800000,"exchange":"NASDAQ","adjPreClose":2.29,"preHourTrading":{"tag":"盘前","latestPrice":2.27,"preClose":2.29,"latestTime":"09:27 EDT","volume":9002,"amount":21002.8884716,"timestamp":1787750836598,"change":-0.02,"changeRate":-0.008734,"amplitude":0.10917},"postHourTrading":{"tag":"盘后","latestPrice":2.46,"preClose":2.45,"latestTime":"19:58 EDT","volume":22855,"amount":55934.3683,"timestamp":1787788692071,"change":0.01,"changeRate":0.004082,"amplitude":0.037959},"volumeRatio":3.944825},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABT\",,,,,undefined,":{"symbol":"LABT","floatShares":1415552,"roa":"-139.40%","roe":"-402.84%","lyrEps":-8.39872,"volumeRatio":3.944825,"shares":2369700,"dividePrice":0,"high":2.57,"amplitude":0.161572,"preClose":2.29,"low":2.2,"week52Low":1.66,"pbRate":"1.34","week52High":98.2,"institutionHeld":0,"latestPrice":2.45,"eps":-10.199959,"divideRate":0,"volume":386271,"delay":0,"ttmEps":-10.199959,"open":2.23,"prevYearClose":80,"prevWeekClose":2.24,"prevMonthClose":2.02,"prevQuarterClose":3.14,"fiveDayClose":2.24,"twentyDayClose":1.98,"sixtyDayClose":6.499},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-06-22","symbol":"LABT","defaultRemindTime":1782135000000,"type":"split","dateTimestamp":1782100800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LABT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LABT","date":"2026-08-25","current":-0.240197,"percent":0.907895,"low":-12.282138,"twenty":-2.792139,"median":-1.209679,"eighty":-0.757424,"high":-0.62611,"avg":-2.678535,"sd":3.288852,"marketCap":5047435},"quantilePoints":[{"date":"2026-05-08","current":-12.282138,"twenty":-12.192813,"median":-11.891342,"eighty":-11.604759,"marketCap":47257207},{"date":"2026-05-15","current":-7.294845,"twenty":-12.043939,"median":-11.649421,"eighty":-11.314454,"marketCap":28067917},{"date":"2026-05-22","current":-2.865088,"twenty":-11.850402,"median":-11.258627,"eighty":-3.412052,"marketCap":11023817},{"date":"2026-05-29","current":-2.716586,"twenty":-11.716415,"median":-6.438817,"eighty":-2.758568,"marketCap":10452435},{"date":"2026-06-05","current":-2.512255,"twenty":-11.604759,"median":-3.225364,"eighty":-2.559299,"marketCap":9666247},{"date":"2026-06-12","current":-2.69016,"twenty":-11.537766,"median":-2.813168,"eighty":-2.512255,"marketCap":10350760},{"date":"2026-06-18","current":-2.241304,"twenty":-11.42611,"median":-2.776507,"eighty":-2.512255,"marketCap":8623724},{"date":"2026-06-26","current":-1.276597,"twenty":-10.242559,"median":-2.72924,"eighty":-2.388094,"marketCap":4911883},{"date":"2026-07-02","current":-1.116845,"twenty":-7.294845,"median":-2.69016,"eighty":-1.477578,"marketCap":4725718},{"date":"2026-07-10","current":-0.893476,"twenty":-5.58279,"median":-2.580737,"eighty":-1.276597,"marketCap":3780575},{"date":"2026-07-17","current":-0.62611,"twenty":-3.536511,"median":-2.512255,"eighty":-1.062695,"marketCap":2649266},{"date":"2026-07-24","current":-1.03562,"twenty":-3.225364,"median":-2.41344,"eighty":-0.92732,"marketCap":4382030},{"date":"2026-07-31","current":-0.653185,"twenty":-2.937143,"median":-2.34533,"eighty":-0.879262,"marketCap":2763829},{"date":"2026-08-07","current":-0.754716,"twenty":-2.857942,"median":-1.477578,"eighty":-0.80819,"marketCap":3193440},{"date":"2026-08-14","current":-0.78856,"twenty":-2.830251,"median":-1.371504,"eighty":-0.793975,"marketCap":3336643},{"date":"2026-08-21","current":-0.706322,"twenty":-2.806803,"median":-1.276597,"eighty":-0.779084,"marketCap":5189616},{"date":"2026-08-25","current":-0.686971,"twenty":-2.792139,"median":-1.209679,"eighty":-0.757424,"marketCap":5047435}],"updateTime":1787811068821},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABT\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659110010","title":"Lakewood-Amedex Q2 FY26 Net Loss Widens to $3.77 Million; R&D Expense More than Doubled to $503,020","url":"https://stock-news.laohu8.com/highlight/detail?id=2659110010","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659110010?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:08","pubTimestamp":1786702114,"startTime":"0","endTime":"0","summary":"Lakewood-Amedex Q2 FY26 net loss widens to $3.77 million; R&D expense more than doubled to $503,020Lakewood-Amedex posted a net loss of $3.77 million for the quarter ended June 30, 2026, widening from the prior-year period.Operating loss widened to $3.79 million as total operating expenses climbed to $3.79 million.Research and development spending more than doubled to $503,020, driven by higher manufacturing, regulatory and clinical planning for Nu-3 Phase 2a.General and administrative costs jumped to $3.29 million, mainly due to $2.4 million in noncash professional services tied to stock issuance.Series C Convertible Preferred Stock private placement raised about $6.8 million net; common stock began trading on Nasdaq Capital Market on April 23.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not b","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL2kZSYf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LABT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954040","title":"Lakewood-Amedex Biotherapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954040","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954040?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:14","pubTimestamp":1786396498,"startTime":"0","endTime":"0","summary":"Lakewood-Amedex Biotherapeutics announces annual shareholder meetingLakewood-Amedex Biotherapeutics will hold its annual shareholder meeting virtually on Sept. 22, 2026.Shareholders will vote to elect","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL8pvPMK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655939386","title":"Lakewood-Amedex Biotherapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2655939386","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655939386?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:33","pubTimestamp":1785443614,"startTime":"0","endTime":"0","summary":"Lakewood-Amedex Biotherapeutics announces annual shareholder meetingLakewood-Amedex Biotherapeutics will hold its annual stockholder meeting virtually on September 22, 2026.Shareholders will vote on e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL4nbJ9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653577357","title":"Lakewood-amedex Biotherapeutics Flags New Press Release Available on Nu-3 Resistance Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2653577357","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653577357?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:04","pubTimestamp":1784721865,"startTime":"0","endTime":"0","summary":"Lakewood-Amedex Biotherapeutics flags new press release available on Nu-3 resistance dataLakewood-Amedex published a July 22, 2026 release highlighting new resistance data for Nu-3, its Phase 2-ready ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL5F7T3W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LABT\",params:#limit:6,delay:false,,,undefined,":[]}}